Apr 1 |
OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp
|
Apr 1 |
Critical Insights From OPKO Health Analyst Ratings: What You Need To Know
|
Apr 1 |
Labcorp (LH) to Boost Clinical Diagnostics With New Deal
|
Mar 29 |
Labcorp inks $237.5M buyout of Opko’s reproductive, women’s health testing assets
|
Mar 28 |
Labcorp to buy select assets from OPKO’s BioReference Health
|
Mar 28 |
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
|
Mar 25 |
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
|
Mar 20 |
Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
|
Mar 5 |
AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV
|
Mar 1 |
Analysts Have Lowered Expectations For OPKO Health, Inc. (NASDAQ:OPK) After Its Latest Results
|